Letter by Chen et al Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”
Circulation · 04.08.2026 · 154 (5)
DOI: 10.1161/circulationaha.125.078086 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, erschienen am 04.08.2026. Verfasst von Qingyu Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, People's Republic of China (Q.C., R.D…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of General Practice, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Province, People's Republic of China (Q.C., R.D.).
- Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang Province, People's Republic of China (Q.C., S.J.).
ORCID-Profile: Qingyu Chen, Sujing Jiang, Ruoshu Duan
Zitieren
APA
Chen, Q., Jiang, S., & Duan, R. (2026). Letter by Chen et al Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”. Circulation, 154(5). https://doi.org/10.1161/circulationaha.125.078086
Vancouver
Chen Q, Jiang S, Duan R. Letter by Chen et al Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”. Circulation. 2026;154(5). doi:10.1161/circulationaha.125.078086
BibTeX
@article{Chen2026,
author = {Chen, Qingyu and Jiang, Sujing and Duan, Ruoshu},
title = {Letter by Chen et al Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”},
journal = {Circulation},
year = {2026},
volume = {154},
number = {5},
doi = {10.1161/circulationaha.125.078086}
}
EUVIMED